Same table, further out: of US men alive at 49 on the SSA 2023 period life table, 999 of 91,565 reach 100, so 1.1%. Period tables freeze today's death rates for the next 51 years, and continued improvement at the historical pace would roughly double that. Getting from there to this market's 38% needs his mortality hazard cut by about four fifths at every age for the rest of his life, which no intervention has achieved in a controlled trial in any mammal; the best replicated drug effect, rapamycin in the NIA mouse program, is a 23 to 26% gain in median lifespan. If something in his regimen really does that, the first place it could be shown in a trial is in dogs, where a lifespan result takes about 4.6 years rather than 21. The arithmetic with sources (mine): https://w0lph.github.io/k9/why-dogs.html?v=2

Why the path to human longevity runs through dogs

Computed from the cited life tables and trials: a lifespan answer takes 4.6 years in dogs and 21 in people; dogs share our environment and diseases, lifespan has already been extended in dogs, and a regulator has accepted lifespan extension as an indication for dog drugs.

upgraded to basic

@strutheo imagine this was some deprecated liquidity system?

bump

only ~53 more years